AAAAAA

   
Results: 1-7 |
Results: 7
THE EFFECT OF 6 MONTHS TREATMENT WITH A 100 MG DAILY DOSE OF DEHYDROEPIANDROSTERONE (DHEA) ON CIRCULATING SEX STEROIDS, BODY-COMPOSITION AND MUSCLE STRENGTH IN AGE-ADVANCED MEN AND WOMEN
Authors: MORALES AJ HAUBRICH RH HWANG JY ASAKURA H YEN SSC
Citation: Aj. Morales et al., THE EFFECT OF 6 MONTHS TREATMENT WITH A 100 MG DAILY DOSE OF DEHYDROEPIANDROSTERONE (DHEA) ON CIRCULATING SEX STEROIDS, BODY-COMPOSITION AND MUSCLE STRENGTH IN AGE-ADVANCED MEN AND WOMEN, Clinical endocrinology, 49(4), 1998, pp. 421-432
IDENTIFICATION OF PATIENTS WITH ACUTE AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS WHO CAN BE EFFECTIVELY TREATED WITH FLUCONAZOLE - THE ROLE OFANTIFUNGAL SUSCEPTIBILITY TESTING
Authors: WITT MD LEWIS RJ LARSEN RA MILEFCHIK EN LEAL MAE HAUBRICH RH RICHIE JA EDWARDS JE GHANNOUM MA
Citation: Md. Witt et al., IDENTIFICATION OF PATIENTS WITH ACUTE AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS WHO CAN BE EFFECTIVELY TREATED WITH FLUCONAZOLE - THE ROLE OFANTIFUNGAL SUSCEPTIBILITY TESTING, Clinical infectious diseases, 22(2), 1996, pp. 322-328
A TRIAL COMPARING NUCLEOSIDE MONOTHERAPY WITH COMBINATION THERAPY IN HIV-INFECTED ADULTS WITH CD4 CELL COUNTS FROM 200 TO 500 PER CUBIC MILLIMETER
Authors: HAMMER SM KATZENSTEIN DA HUGHES MD GUNDACKER H SCHOOLEY RT HAUBRICH RH HENRY WK LEDERMAN MM PHAIR JP NIU M HIRSCH MS MERIGAN TC BLASCHKE TF SIMPSON D MCLAREN C ROONEY J SALGO M
Citation: Sm. Hammer et al., A TRIAL COMPARING NUCLEOSIDE MONOTHERAPY WITH COMBINATION THERAPY IN HIV-INFECTED ADULTS WITH CD4 CELL COUNTS FROM 200 TO 500 PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1081-1090
DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX - CORRELATION BETWEEN BLOOD AND TISSUE BURDEN
Authors: TORRIANI FJ BEHLING CA MCCUTCHAN JA HAUBRICH RH HAVLIR DV
Citation: Fj. Torriani et al., DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX - CORRELATION BETWEEN BLOOD AND TISSUE BURDEN, The Journal of infectious diseases, 173(4), 1996, pp. 942-949
A RANDOMIZED TRIAL OF THE ACTIVITY AND SAFETY OF RO-24-7429 (TAT ANTAGONIST) VERSUS NUCLEOSIDE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: HAUBRICH RH FLEXNER C LEDERMAN MM HIRSCH M PETTINELLI CP GINSBERG R LIETMAN P HAMZEH FM SPECTOR SA RICHMAN DD HAMMER S COOLEY T GULICK R SULLIVAN M SPINA C FRASER A LATHEY J BASSIAKOS Y CHANCE M DROBNES C CORUELL E GRUE L RAINES C KUWAHARA S MCPHERSON J
Citation: Rh. Haubrich et al., A RANDOMIZED TRIAL OF THE ACTIVITY AND SAFETY OF RO-24-7429 (TAT ANTAGONIST) VERSUS NUCLEOSIDE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 172(5), 1995, pp. 1246-1252
HIGH-DOSE FLUCONAZOLE FOR TREATMENT OF CRYPTOCOCCAL DISEASE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: HAUBRICH RH HAGHIGHAT D BOZZETTE SA TILLES J MCCUTCHAN JA
Citation: Rh. Haubrich et al., HIGH-DOSE FLUCONAZOLE FOR TREATMENT OF CRYPTOCOCCAL DISEASE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 170(1), 1994, pp. 238-242
SAFETY AND IMMUNOGENICITY OF A MONOCLONAL ANTIIDIOTYPE ANTIBODY (3C9)PLUS SAF-M ADJUVANT FOR HIV-INFECTED PATIENTS
Authors: HAUBRICH RH MCCUTCHAN JA CARALLI V SPECTOR SA JACOBSEN C KANG C MERRITT J
Citation: Rh. Haubrich et al., SAFETY AND IMMUNOGENICITY OF A MONOCLONAL ANTIIDIOTYPE ANTIBODY (3C9)PLUS SAF-M ADJUVANT FOR HIV-INFECTED PATIENTS, Journal of cellular biochemistry, 1993, pp. 79-79
Risultati: 1-7 |